133 related articles for article (PubMed ID: 3186742)
21. IFN regulatory factor-1 gene transfer into an aggressive, nonimmunogenic sarcoma suppresses the malignant phenotype and enhances immunogenicity in syngeneic mice.
Yim JH; Wu SJ; Casey MJ; Norton JA; Doherty GM
J Immunol; 1997 Feb; 158(3):1284-92. PubMed ID: 9013971
[TBL] [Abstract][Full Text] [Related]
22. Role of endogenous peptides in murine allogenic cytotoxic T cell responses assessed using transfectants of the antigen-processing mutant 174xCEM.T2.
Crumpacker DB; Alexander J; Cresswell P; Engelhard VH
J Immunol; 1992 May; 148(10):3004-11. PubMed ID: 1374446
[TBL] [Abstract][Full Text] [Related]
23. Expression of two H-2K genes, syngeneic and allogeneic, as a strategy for potentiating immune recognition of tumor cells.
Mandelboim O; Vadai E; Feldman M; Eisenbach L
Gene Ther; 1995 Dec; 2(10):757-65. PubMed ID: 8750016
[TBL] [Abstract][Full Text] [Related]
24. Adenoviral transfer of xenogeneic MHC class I gene results in loss of tumorigenicity and inhibition of tumor growth.
Campbell I; Moyana T; Carlsen S; Zheng C; Xiang J
Cancer Gene Ther; 2000 Jan; 7(1):37-44. PubMed ID: 10678354
[TBL] [Abstract][Full Text] [Related]
25. Molecular analysis of deficient class I H-2 antigen expression by mouse lung carcinoma cells.
Bahler DW; Cerosaletti KM; Lord EM; Frelinger JG
J Immunol; 1988 Jun; 140(11):4003-12. PubMed ID: 2453562
[TBL] [Abstract][Full Text] [Related]
26. Transduction of genes coding for a histocompatibility (MHC) antigen and for its physiological inducer interferon-gamma in the same cell: efficient MHC expression and inhibition of tumor and metastasis growth.
Lollini PL; De Giovanni C; Landuzzi L; Nicoletti G; Frabetti F; Cavallo F; Giovarelli M; Forni G; Modica A; Modesti A
Hum Gene Ther; 1995 Jun; 6(6):743-52. PubMed ID: 7548274
[TBL] [Abstract][Full Text] [Related]
27. Expression of H-2Dd and H-2Ld mouse major histocompatibility antigen genes in L cells after DNA-mediated gene transfer.
Margulies DH; Evans GA; Ozato K; Camerini-Otero RD; Tanaka K; Appella E; Seidman JG
J Immunol; 1983 Jan; 130(1):463-70. PubMed ID: 6571712
[TBL] [Abstract][Full Text] [Related]
28. Auto-delayed-type hypersensitivity induced in immunodeficient mice with modified self-antigens. V. Cellular autoreactivity directed against self-H-2Dd subregion mediates the inflammatory responses.
Tarcic N; David CS; Naor D
Immunology; 1989 Jun; 67(2):184-90. PubMed ID: 2502495
[TBL] [Abstract][Full Text] [Related]
29. Suppression of beta-catenin inhibits the neoplastic growth of APC-mutant colon cancer cells.
Roh H; Green DW; Boswell CB; Pippin JA; Drebin JA
Cancer Res; 2001 Sep; 61(17):6563-8. PubMed ID: 11522655
[TBL] [Abstract][Full Text] [Related]
30. Rejection of K1735 murine melanoma in syngeneic hosts requires expression of MHC class I antigens and either class II antigens or IL-2.
Chen PW; Ananthaswamy HN
J Immunol; 1993 Jul; 151(1):244-55. PubMed ID: 8326126
[TBL] [Abstract][Full Text] [Related]
31. Insulin-like growth factor 1 receptor enhances invasion and induces resistance to apoptosis of colon cancer cells through the Akt/Bcl-x(L) pathway.
Sekharam M; Zhao H; Sun M; Fang Q; Zhang Q; Yuan Z; Dan HC; Boulware D; Cheng JQ; Coppola D
Cancer Res; 2003 Nov; 63(22):7708-16. PubMed ID: 14633695
[TBL] [Abstract][Full Text] [Related]
32. Tumorigenic conversion of p53-deficient colon epithelial cells by an activated Ki-ras gene.
Sevignani C; Wlodarski P; Kirillova J; Mercer WE; Danielson KG; Iozzo RV; Calabretta B
J Clin Invest; 1998 Apr; 101(8):1572-80. PubMed ID: 9541486
[TBL] [Abstract][Full Text] [Related]
33. The cytoplasmic domain is critical to the tumor suppressor activity of TSLC1 in non-small cell lung cancer.
Mao X; Seidlitz E; Ghosh K; Murakami Y; Ghosh HP
Cancer Res; 2003 Nov; 63(22):7979-85. PubMed ID: 14633730
[TBL] [Abstract][Full Text] [Related]
34. Modulation of the tumorigenicity of human adenovirus-12-transformed cells by interferon.
Hayashi H; Tanaka K; Jay F; Khoury G; Jay G
Cell; 1985 Nov; 43(1):263-7. PubMed ID: 4075396
[TBL] [Abstract][Full Text] [Related]
35. Transfection and expression of mutant p53 protein does not alter the in vivo or in vitro growth characteristics of the AA/C1 human adenoma derived cell line, including sensitivity to transforming growth factor-beta 1.
Williams AC; Browne SJ; Manning AM; Daffada P; Collard TJ; Paraskeva C
Oncogene; 1994 May; 9(5):1479-85. PubMed ID: 8152811
[TBL] [Abstract][Full Text] [Related]
36. Increased cell-substratum adhesion, and decreased gelatinase secretion and cell growth, induced by E-cadherin transfection of human colon carcinoma cells.
Miyaki M; Tanaka K; Kikuchi-Yanoshita R; Muraoka M; Konishi M; Takeichi M
Oncogene; 1995 Dec; 11(12):2547-52. PubMed ID: 8545111
[TBL] [Abstract][Full Text] [Related]
37. [Effects of hMIP-1beta gene modification on in vivo tumorigenicity and vaccine efficacy of tumor cells].
Luo XL; Xie YA; Kuang ZP; Wu JN; Liang AM
Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):97-102. PubMed ID: 18646689
[TBL] [Abstract][Full Text] [Related]
38. Suppression of tumorigenicity in hybrids of tumorigenic Chinese hamster cells and diploid mouse fibroblasts: dependence on the presence of at least three different mouse chromosomes and independence of hamster genome dosage.
Schäfer R; Hoffmann H; Willecke K
Cancer Res; 1983 May; 43(5):2240-6. PubMed ID: 6831446
[TBL] [Abstract][Full Text] [Related]
39. The effect of eicosanoids on the expression of MHC genes in cultured human colon cancer cells and mouse colonocytes in vivo.
Feng Y; Papavassiliou ED; Arvind P; Tsioulias GJ; Rigas B
Prostaglandins Leukot Essent Fatty Acids; 1996 Dec; 55(6):373-8. PubMed ID: 9014214
[TBL] [Abstract][Full Text] [Related]
40. Expression of major histocompatibility complex class I antigens as a strategy for the potentiation of immune recognition of tumor cells.
Tanaka K; Hayashi H; Hamada C; Khoury G; Jay G
Proc Natl Acad Sci U S A; 1986 Nov; 83(22):8723-7. PubMed ID: 3464979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
